Floatz logo

Unfractionated Heparin

Venous Thromboembolism

Wuhan Asia Heart HospitalUNKNOWNPhase 4 / ApprovedDormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the Venous Thromboembolism cohort.

Asset / SponsorPhaseRating
Warfarin
Northern Jiangsu People's Hospital
Phase 4A
Apixaban
Regeneron Pharmaceuticals
Phase 4BBB
Aspirin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4BBB
Nadroparin
Rijnstate Hospital
Phase 4BBB
Rivaroxaban
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3BBB

View all 28 →

Same molecule, other indications

Unfractionated Heparin is also rated in:

childhood acute lymphoblastic leukemiaDormant
B
Indicative · Phase 4
59 / 100
View asset →
myocardial infarctionDormant
B
Indicative · Phase 4
57 / 100
View asset →
vertebral artery dissectionDormant
B
Indicative · Phase 3
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →